Career Opportunities


CavtheRx is a pre-clinical stage biopharmaceutical company focused on developing innovative caveolin modulators which have been shown to regulate signal transduction pathways. The unique mechanisms of action that provide anti-angiogenic and anti-inflammatory effects which block vascular leakage and edema suggest that caveolin modulators may have a role in addressing a wide range of chronic disease states. Our initial development plans focus on the treatment of sight-threatening neovascular eye diseases which include neovascular age-related macular degeneration (wet AMD), the leading cause of blindness in the Western world, and diabetic retinopathy. Despite the advances in treatment provided by anti-VEGF agents, studies have reported up to 40% of patients achieve sub-optimal BCVA results. In vitro and in vivo models demonstrate inhibition of CNV with Cavtratin alone and a synergestic effect with anti-VEGF therapy.
Inaccurate data? Flag it here.
Open jobs at CavtheRx
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Connecticut Innovations to understand how it is being used. Read our Cookie Policy.